Literature DB >> 20526019

Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood.

Fatih Ermis1, Kemal Oncu, Melih Ozel, Yusuf Yazgan, Ahmet Kemal Gurbuz, Levent Demirturk, Hakan Demirci, Taner Akyol, Aptullah Hahoglu.   

Abstract

Benign recurrent intrahepatic cholestasis (BRIC) is a rare autosomal recessive or sporadic disorder, characterized by recurrent episodes of intense pruritus and jaundice that resolve spontaneously without leaving considerable liver damage. The attacks can start at any age, but the first attack is usually seen before the second decade of life. We report the case of a young adult male patient with BRIC who presented with recurrent cholestatic jaundice and pruritus with negative work up for all possible etiologies and a liver biopsy consistent with intrahepatic cholestasis. He improved on treatment with rifampicin and has not suffered another attack on follow up. Although in adulthood, BRIC diagnosis should be kept in mind in patients with recurrent cholestatic attacks with symptom free intervals after main bile duct obstruction and other congenital or acquired causes of intrahepatic cholestasis excluded.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526019

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  4 in total

1.  New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.

Authors:  Hamoud Alhebbi; Abdul Ali Peer-Zada; Abdulrahman A Al-Hussaini; Sara Algubaisi; Awad Albassami; Nasser AlMasri; Yasir Alrusayni; Ibrahim M Alruzug; Essa Alharby; Manar A Samman; Syed Zubair Ayoub; Sateesh Maddirevula; Roy W A Peake; Fowzan S Alkuraya; Sami Wali; Naif A M Almontashiri
Journal:  J Hum Genet       Date:  2020-08-06       Impact factor: 3.172

2.  Clinical challenge in hepatology.

Authors:  Alireza Norouzi; Sadaf Ghajarieh Sepanlou; Samaneh Tavassoli; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2011-09

3.  A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients.

Authors:  Vanessa Baier; Henrik Cordes; Christoph Thiel; José V Castell; Ulf P Neumann; Lars M Blank; Lars Kuepfer
Journal:  Front Physiol       Date:  2019-09-27       Impact factor: 4.566

4.  Coronavirus disease 2019 (COVID-19) as a potential trigger for benign recurrent intrahepatic cholestasis.

Authors:  Turan Çalhan; Elif Yivli
Journal:  Clin Case Rep       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.